Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.31 billion. The enterprise value is $1.06 billion.
| Market Cap | 1.31B |
| Enterprise Value | 1.06B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 71.08 million shares outstanding. The number of shares has decreased by -15.00% in one year.
| Current Share Class | 71.08M |
| Shares Outstanding | 71.08M |
| Shares Change (YoY) | -15.00% |
| Shares Change (QoQ) | -1.84% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 102.69% |
| Float | 66.87M |
Valuation Ratios
The trailing PE ratio is 7.27 and the forward PE ratio is 9.16. Innoviva's PEG ratio is 3.05.
| PE Ratio | 7.27 |
| Forward PE | 9.16 |
| PS Ratio | 3.00 |
| Forward PS | 2.83 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | 7.20 |
| P/OCF Ratio | 7.16 |
| PEG Ratio | 3.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.28, with an EV/FCF ratio of 5.78.
| EV / Earnings | 5.46 |
| EV / Sales | 2.41 |
| EV / EBITDA | 5.28 |
| EV / EBIT | 6.10 |
| EV / FCF | 5.78 |
Financial Position
The company has a current ratio of 15.44, with a Debt / Equity ratio of 0.29.
| Current Ratio | 15.44 |
| Quick Ratio | 13.84 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 1.81 |
| Interest Coverage | 8.79 |
Financial Efficiency
Return on equity (ROE) is 18.02% and return on invested capital (ROIC) is 16.04%.
| Return on Equity (ROE) | 18.02% |
| Return on Assets (ROA) | 7.29% |
| Return on Invested Capital (ROIC) | 16.04% |
| Return on Capital Employed (ROCE) | 11.63% |
| Weighted Average Cost of Capital (WACC) | 6.05% |
| Revenue Per Employee | $2.76M |
| Profits Per Employee | $1.22M |
| Employee Count | 159 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.49 |
Taxes
In the past 12 months, Innoviva has paid $30.53 million in taxes.
| Income Tax | 30.53M |
| Effective Tax Rate | 13.63% |
Stock Price Statistics
The stock price has decreased by -16.90% in the last 52 weeks. The beta is 0.37, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -16.90% |
| 50-Day Moving Average | 20.64 |
| 200-Day Moving Average | 21.88 |
| Relative Strength Index (RSI) | 28.72 |
| Average Volume (20 Days) | 873,318 |
Short Selling Information
The latest short interest is 7.50 million, so 10.54% of the outstanding shares have been sold short.
| Short Interest | 7.50M |
| Short Previous Month | 7.27M |
| Short % of Shares Out | 10.54% |
| Short % of Float | 11.21% |
| Short Ratio (days to cover) | 11.18 |
Income Statement
In the last 12 months, Innoviva had revenue of $438.32 million and earned $193.44 million in profits. Earnings per share was $2.54.
| Revenue | 438.32M |
| Gross Profit | 337.37M |
| Operating Income | 173.08M |
| Pretax Income | 223.97M |
| Net Income | 193.44M |
| EBITDA | 199.81M |
| EBIT | 173.08M |
| Earnings Per Share (EPS) | $2.54 |
Balance Sheet
The company has $590.06 million in cash and $331.04 million in debt, with a net cash position of $259.03 million or $3.64 per share.
| Cash & Cash Equivalents | 590.06M |
| Total Debt | 331.04M |
| Net Cash | 259.03M |
| Net Cash Per Share | $3.64 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 15.90 |
| Working Capital | 722.22M |
Cash Flow
In the last 12 months, operating cash flow was $183.47 million and capital expenditures -$955,000, giving a free cash flow of $182.51 million.
| Operating Cash Flow | 183.47M |
| Capital Expenditures | -955,000 |
| Depreciation & Amortization | 26.73M |
| Net Borrowing | n/a |
| Free Cash Flow | 182.51M |
| FCF Per Share | $2.57 |
Margins
Gross margin is 76.97%, with operating and profit margins of 39.49% and 44.13%.
| Gross Margin | 76.97% |
| Operating Margin | 39.49% |
| Pretax Margin | 51.10% |
| Profit Margin | 44.13% |
| EBITDA Margin | 45.58% |
| EBIT Margin | 39.49% |
| FCF Margin | 41.64% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 15.00% |
| Shareholder Yield | 15.00% |
| Earnings Yield | 13.76% |
| FCF Yield | 13.89% |
Analyst Forecast
The average price target for Innoviva is $34.80, which is 88.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $34.80 |
| Price Target Difference | 88.21% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.18% |
| EPS Growth Forecast (3Y) | 12.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innoviva has an Altman Z-Score of 3.82 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 6 |